Investigation of effectiveness of radiofrequency ablation in beta thalassemia patients, considering hematologic parameters

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT138712141738N1

Enrollment

Registered

2009-05-29

Start date

2008-07-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Beta thalassemia. Cooley's anaemia

Interventions

Intervention 1: Radiofrequency ablation of spleen in beta thalassemia using Cooltip Radionics RF Probe. Intervention 2: Partial splenectomy. Intervention 3: Total splenectomy.

Treatment - Surgery

Radiofrequency ablation of spleen in beta thalassemia using Cooltip Radionics RF Probe.

Partial splenectomy

Total splenectomy

Eligibility

Sex/Gender

All

Age

5 Years to 20 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:beta thalassemia Exclusion criteria: positive direct or indirect coombs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Level of Hb. Timepoint: 3 month follow-up period. Method of measurement: CBC.;Platelet count. Timepoint: 3 month follow-up period. Method of measurement: CBC.	—

Secondary

Measure	Time frame
Need to transfusion. Timepoint: 3 months follow-up period. Method of measurement: transfusion volume and intervals.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Naderifar

Shiraz University of Medical Sciences

mehdinaderifar2000@yahoo.com+98 71 1647 3233

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026